AKT1 and colorectal cancer: In colorectal cancer, RPF2 is significantly overexpressed, promoting epithelial-mesenchymal transition (EMT) via the AKT/GSK-3β signaling pathway, thereby enhancing migration and invasion of colorectal cancer cells in vitro and vivo [46].